Published in Clin Microbiol Infect on February 02, 2010
Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae. PLoS One (2016) 1.40
ESSENTIALS: software for rapid analysis of high throughput transposon insertion sequencing data. PLoS One (2012) 1.35
Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev (2012) 1.31
Complete genome sequence of a serotype 11A, ST62 Streptococcus pneumoniae invasive isolate. BMC Microbiol (2011) 1.03
Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol (2014) 1.03
Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm (2013) 1.01
Licensing Adaptive Immunity by NOD-Like Receptors. Front Immunol (2013) 0.99
Regulation of arginine acquisition and virulence gene expression in the human pathogen Streptococcus pneumoniae by transcription regulators ArgR1 and AhrC. J Biol Chem (2011) 0.98
Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells. J Biol Chem (2013) 0.98
Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins. Eur J Clin Microbiol Infect Dis (2010) 0.98
Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designation. BMC Genomics (2013) 0.94
Parallel evolution of Streptococcus pneumoniae and Streptococcus mitis to pathogenic and mutualistic lifestyles. MBio (2014) 0.92
The C-type lectin receptor Mincle binds to Streptococcus pneumoniae but plays a limited role in the anti-pneumococcal innate immune response. PLoS One (2015) 0.91
Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage. Infect Immun (2012) 0.89
Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity. PLoS One (2013) 0.88
Inhibition of competence development, horizontal gene transfer and virulence in Streptococcus pneumoniae by a modified competence stimulating peptide. PLoS Pathog (2011) 0.87
Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol (2011) 0.87
Pneumococcal hydrogen peroxide-induced stress signaling regulates inflammatory genes. J Infect Dis (2014) 0.87
Identification of an atypical zinc metalloproteinase, ZmpC, from an epidemic conjunctivitis-causing strain of Streptococcus pneumoniae. Microb Pathog (2012) 0.83
Inhibitors of Streptococcus pneumoniae surface endonuclease EndA discovered by high-throughput screening using a PicoGreen fluorescence assay. J Biomol Screen (2012) 0.82
Development of primary invasive pneumococcal disease caused by serotype 1 pneumococci is driven by early increased type I interferon response in the lung. Infect Immun (2014) 0.82
Streptococcus pneumoniae induces autophagy through the inhibition of the PI3K-I/Akt/mTOR pathway and ROS hypergeneration in A549 cells. PLoS One (2015) 0.82
Contribution of different pneumococcal virulence factors to experimental meningitis in mice. BMC Infect Dis (2013) 0.82
Functionally cloned pdrM from Streptococcus pneumoniae encodes a Na(+) coupled multidrug efflux pump. PLoS One (2013) 0.82
Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus. PLoS Pathog (2014) 0.81
Insights into the Evolutionary Relationships of LytA Autolysin and Ply Pneumolysin-Like Genes in Streptococcus pneumoniae and Related Streptococci. Genome Biol Evol (2015) 0.81
Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies. Clin Vaccine Immunol (2014) 0.81
A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection. Mol Cell Proteomics (2015) 0.81
Adenylate kinase from Streptococcus pneumoniae is essential for growth through its catalytic activity. FEBS Open Bio (2014) 0.80
Virulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future Vaccines. PLoS One (2015) 0.80
Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae. PLoS One (2015) 0.79
Infectious keratitis: secreted bacterial proteins that mediate corneal damage. J Ophthalmol (2013) 0.78
Diversity of Pneumolysin and Pneumococcal Histidine Triad Protein D of Streptococcus pneumoniae Isolated from Invasive Diseases in Korean Children. PLoS One (2015) 0.77
Infection of zebrafish embryos with live fluorescent Streptococcus pneumoniae as a real-time pneumococcal meningitis model. J Neuroinflammation (2016) 0.77
A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood. Sci Rep (2017) 0.77
A Serine-Threonine Kinase (StkP) Regulates Expression of the Pneumococcal Pilus and Modulates Bacterial Adherence to Human Epithelial and Endothelial Cells In Vitro. PLoS One (2015) 0.76
Two-component system response regulators involved in virulence of Streptococcus pneumoniae TIGR4 in infective endocarditis. PLoS One (2013) 0.76
Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue. PLoS One (2015) 0.76
Streptococcus pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target. PLoS One (2016) 0.75
Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media. Front Cell Infect Microbiol (2016) 0.75
Co-Transcriptomes of Initial Interactions In Vitro between Streptococcus Pneumoniae and Human Pleural Mesothelial Cells. PLoS One (2015) 0.75
Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children. Sci Rep (2016) 0.75
In vitro expression of Streptococcus pneumoniae ply gene in human monocytes and pneumocytes. Eur J Med Res (2015) 0.75
NLRP3 protects alveolar barrier integrity by an inflammasome-independent increase of epithelial cell adherence. Sci Rep (2016) 0.75
Potential Usefulness of Streptococcus pneumoniae Extracellular Membrane Vesicles as Antibacterial Vaccines. J Immunol Res (2017) 0.75
Detection of lytA, pspC, and rrgA genes in Streptococcus pneumoniae isolated from healthy children. Iran J Microbiol (2015) 0.75
Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia. Sci Rep (2016) 0.75
Induction of Central Host Signaling Kinases during Pneumococcal Infection of Human THP-1 Cells. Front Cell Infect Microbiol (2016) 0.75
Comparative Genomics of Carriage and Disease Isolates of Streptococcus pneumoniae Serotype 22F Reveals Lineage-Specific Divergence and Niche Adaptation. Genome Biol Evol (2016) 0.75
Highly specific and rapid glycan based amperometric detection of influenza viruses. Chem Sci (2017) 0.75
The FAD synthetase from the human pathogen Streptococcus pneumoniae: a bifunctional enzyme exhibiting activity-dependent redox requirements. Sci Rep (2017) 0.75
Strain Level Streptococcus Colonization Patterns during the First Year of Life. Front Microbiol (2017) 0.75
Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol (1993) 3.09
Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun (1994) 3.01
Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled by an autoinduced peptide. J Bacteriol (2000) 2.85
Host cellular immune response to pneumococcal lung infection in mice. Infect Immun (2000) 2.74
Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun (1994) 2.49
The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis (1995) 2.47
Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun (1991) 2.32
Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol Microbiol (1991) 2.11
A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect Immun (1994) 2.04
Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut (1986) 1.93
Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity. Infect Immun (1989) 1.91
Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect Immun (2001) 1.86
Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest (1995) 1.77
Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect Immun (1995) 1.72
Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae. Infect Immun (2000) 1.69
Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol (1991) 1.64
Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis (2001) 1.62
Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J Med Microbiol (1986) 1.62
A two-component system that controls the expression of pneumococcal surface antigen A (PsaA) and regulates virulence and resistance to oxidative stress in Streptococcus pneumoniae. Mol Microbiol (2004) 1.42
Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect Immun (1995) 1.41
Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect Immun (2000) 1.40
Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med (1996) 1.38
The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb Pathog (1990) 1.37
A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun (1997) 1.36
Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Microb Pathog (1998) 1.35
Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun (2001) 1.35
A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem J (1998) 1.30
The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect Immun (2000) 1.28
The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol (1992) 1.27
Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates. J Environ Pathol Toxicol (1979) 1.23
The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J Mol Biol (1998) 1.20
The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect Immun (2004) 1.17
Self-interaction of pneumolysin, the pore-forming protein toxin of Streptococcus pneumoniae. J Mol Biol (1998) 1.16
Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. J Med Microbiol (1987) 1.13
Pneumolysin activates phospholipase A in pulmonary artery endothelial cells. Infect Immun (1994) 1.13
The hemagglutination-inhibition assay for erythropoietin. Its specificity, reproducibility and sensitivity. Isr J Med Sci (1971) 1.13
Extrapolation of the relative risk of radiogenic neoplasms across mouse strains and to man. Radiat Res (1988) 1.13
Role of two-component systems in the virulence of Streptococcus pneumoniae. J Med Microbiol (2006) 1.12
The dose-response relationship for ethyl methanesulfonate-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells. Somatic Cell Genet (1975) 1.12
ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract. Infect Immun (2003) 1.12
Delta 32 deletion of CCR5 gene and association with asthma or atopy. Lancet (2000) 1.12
Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate. Vaccine (1994) 1.10
Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect Immun (2001) 1.09
A program of statistical designs for optimizing specific transfer ribonucleic acid assay conditions. Anal Chem (1971) 1.08
Nonparametric estimation of the distribution of time to onset for specific diseases in survival/sacrifice experiments. Biometrics (1984) 1.07
Effect of pneumolysin on rat brain ciliary function: comparison of brain slices with cultured ependymal cells. Pediatr Res (2000) 1.06
Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: cloning and expression of a second neuraminidase gene in Escherichia coli. Infect Immun (1991) 1.05
Dynamics of pneumococcal colonization in healthy Dutch children. Microbiology (2006) 1.05
A role in cell-binding for the C-terminus of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae. FEMS Microbiol Lett (1994) 1.05
The effect of the pneumococcal toxin, pneumolysin on brain ependymal cilia. Microb Pathog (1999) 1.04
The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro. Eur Respir J (1992) 1.03
Functional analysis of pneumolysin by use of monoclonal antibodies. Infect Immun (1996) 1.02
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother (2007) 1.01
Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form. J Biol Chem (1994) 1.00
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis. Cell Death Dis (2012) 1.00
Clostridium difficile enterotoxin (toxin A): new results. Biochem Soc Trans (1984) 0.99
Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin, the thiol activated toxin of Streptococcus pneumoniae. Acta Otolaryngol (1993) 0.99
Chloride persistence in a deiced access road drainage system. J Environ Qual (2001) 0.99
Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins. Eur J Clin Microbiol Infect Dis (2010) 0.98
Subunit organisation and symmetry of pore-forming, oligomeric pneumolysin. FEBS Lett (1995) 0.98
Biological mode of action of Clostridium difficile toxin A: a novel enterotoxin. J Med Microbiol (1987) 0.98
Production and release of toxins A and B by Clostridium difficile. J Med Microbiol (1984) 0.98
Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression. Br J Cancer (2010) 0.98
1.2 Angstroms crystal structure of the S. pneumoniae PhtA histidine triad domain a novel zinc binding fold. FEBS Lett (2005) 0.96
Streptococcus pneumoniae produces a second haemolysin that is distinct from pneumolysin. Microb Pathog (1997) 0.96
Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J Clin Microbiol (2009) 0.96
Use of green fluorescent protein in visualisation of pneumococcal invasion of broncho-epithelial cells in vivo. FEMS Microbiol Lett (2001) 0.95
Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. Curr Eye Res (1995) 0.93
The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits. J Med Microbiol (1987) 0.92
Prostatocutaneous urinary fistula to the thigh after retropubic prostatectomy in a patient with polycythaemia rubra vera. Br J Urol (1986) 0.91
The dose-response relationship for ultraviolet-light-induced mutations at the hypoxanthine-guanine phosphoribosyltransferase locus in Chinese hamster ovary cells. Somatic Cell Genet (1975) 0.90
Pneumolysin-mediated activation of NFkappaB in human neutrophils is antagonized by docosahexaenoic acid. Clin Exp Immunol (2005) 0.89
Stimulator requirements for primed alloreactive T cells: macrophages and dendritic cells activate T cells across all genetic disparities. Cell Immunol (1985) 0.88
Molecular epidemiology of penicillin-susceptible non-beta-lactam-resistant Streptococcus pneumoniae isolates from Greek children. J Clin Microbiol (2003) 0.88
Role of interleukin-18 in experimental infections with Streptococcus pneumoniae. J Med Microbiol (2005) 0.87
Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering. J Mol Biol (1999) 0.87
A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome. Eur J Cancer (2013) 0.87
Survival and cause of death in aging germfree athymic nude and normal inbred C3Hf/He mice. J Natl Cancer Inst (1978) 0.86
Relationship of structure to function in pneumolysin. Microb Drug Resist (1997) 0.85
Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils. Eur Respir J (2009) 0.84
Partial complementation of Sinorhizobium meliloti bacA mutant phenotypes by the Mycobacterium tuberculosis BacA protein. J Bacteriol (2012) 0.84
Identification of novel pneumolysin alleles from paediatric carriage isolates of Streptococcus pneumoniae. J Med Microbiol (2010) 0.84
Regulation of transcription of the TATA-less human complement component C4 gene. J Immunol (1998) 0.83
The effects of Clostridium difficile crude toxins and purified toxin A on stripped rabbit ileal mucosa in Ussing chambers. J Med Microbiol (1987) 0.83
The chemistry of pseudomonic acid. 18. Heterocyclic replacement of the alpha,beta-unsaturated ester: synthesis, molecular modeling, and antibacterial activity. J Med Chem (1997) 0.83
Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. J Clin Microbiol (2005) 0.83
Characterisation of an oxidative response inhibitor produced by Streptococcus pneumoniae. Thorax (1994) 0.83
Exploratory analysis of disease prevalence data from survival/sacrifice experiments. Biometrics (1978) 0.82
Amino acids in pneumolysin important for hemolytic activity identified by random mutagenesis. Infect Immun (1994) 0.82
Effects of testosterone and erythropoietin on rabbit bone marrow cells. Isr J Med Sci (1971) 0.81
Chromosome malsegregation and embryonic lethality induced by treatment of normally ovulated mouse oocytes with nocodazole. Mutat Res (1989) 0.81
Carcinogenic and cocarcinogenic effects of inhaled synthetic smog and ferric oxide particles. J Natl Cancer Inst (1975) 0.81
Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother (2007) 0.80
Hyaluronidase augments pneumolysin-mediated injury to human ciliated epithelium. Int J Infect Dis (2006) 0.80
Lifespan and autopsy findings in the first-generation offspring of X-irradiated male mice. Mutat Res (1993) 0.80
Log-linear models in the analysis of disease prevalence data from survival/sacrifice experiments. Biometrics (1979) 0.80
Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia. Am J Respir Crit Care Med (2001) 0.80
Effect of immunization with Freund's adjuvant and pneumolysin on histologic features of pneumococcal infection in the rat lung in vivo. Infect Immun (1992) 0.79
Distribution of epidemic antibiotic-resistant pneumococcal clones in Scottish pneumococcal isolates analysed by multilocus sequence typing. Microbiology (2006) 0.79
The simulation, fitting, and testing of a stochastic cellular proliferation model. Biometrics (1971) 0.79